Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden. (8th May 2017)

Record Type:: Journal Article
Title:: Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden. (8th May 2017)
Main Title:: Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden
Authors:: Syrimi, Eleni
Gunasekera, Sanjeeva
Norton, Alice
Velangi, Mark
Motwani, Jayashree
Hiwarkar, Prashant
Abstract:
Is Part Of:: British journal of haematology. Volume 181:Number 5(2018)
Journal:: British journal of haematology
Issue:: Volume 181:Number 5(2018)
Issue Display:: Volume 181, Issue 5 (2018)
Year:: 2018
Volume:: 181
Issue:: 5
Issue Sort Value:: 2018-0181-0005-0000
Page Start:: 696
Page End:: 698
Publication Date:: 2017-05-08
Subjects:: tumour lysis -- single dose rasburicase -- hyperuricaemia
Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15
Journal URLs:: http://www.blacksci.co.uk/%7Ecgilib/jnlpage.bin?Journal=bjh&File=bjh&Page=aims ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjh.14689 ↗
Languages:: English
ISSNs:: 0007-1048
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2309.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 6716.xml